The Advanced Medical Technology Association (AdvaMed) and Biocom, the association representing the California life science industry, have announced a joint partnership to collaboratively produce The Digital MedTech Conference 2020. In combining Biocom’s DeviceFest and Digital Health Conference with AdvaMed’s Digital MedTech Conference, the single event will highlight the evolving digital medtech landscape and explore trends impacting the industry, all while bringing together key leaders from California and beyond.
Founding Principal, Explore DNA
Mr. Posard brings over 30 years experience of general management and commercialization experience in the diagnostics, life sciences and pharmaceutical industry. Matt’s expertise is introducing novel and transformational products to clinical and research markets while scaling organizations rapidly and efficiently. Matt has held executive title responsibilities with several highly successful growth companies including Illumina, Biosite and Gen-Probe. From 2006 to 2015, Matt held executive positions at Illumina as its VP of Marketing, VP Global Sales and then as Senior VP, General Manager of its Translational and Consumer Genomics and New and Emerging Markets business units. Matt currently serves on multiple boards including Halozyme Therapeutics (NASDAQ: HALO), Dermtech, Talis Biomedical, Ignite Bio, Fabric Genomics and Stemson Therapeutics. Matt holds a Bachelors degree in Management Science from UC San Diego.
The key to positioning a company for financing is creating a strong company value proposition. There are 5 basic elements to a value proposition and they are elements that all investors want to hear and understand. In this panel, we will discuss the basic elements of the value proposition and our panel will provide real […]